The lede in a recent
piece on USAToday
sets the stage: “Higher blood sugar levels, even those well short of diabetes,
seem to raise the risk of developing dementia,
a major new study finds. Researchers say it suggests a novel way to try to
prevent Alzheimer’s disease -- by keeping glucose at a healthy level.” The
article was based on a study at the University of Washington, Seattle, and was published
in the New England Journal of Medicine.
A piece by Megan Brooks in
MedScape Medical News quotes the
study’s lead author, Dr. Paul Crane, as saying, “We considered blood glucose
levels far into the normal (nondiabetic) range, and even there found an
association between higher glucose levels and dementia risk.” “He said the
results suggest that the ‘clinical determination of diabetes/not diabetes may
miss important associations still there for people who are categorized as not
having diabetes’.”
The Associated Press story on the USAToday piece was written by Marilynn
Marchione. She quotes Dallas Anderson, a scientist at the National Institute on
Aging, the federal agency that paid for the study: “It’s a nice clean pattern
-- risk rises as blood sugar does.” According to Marchione, Anderson said, “This
is part of a larger picture” and adds evidence that exercising and controlling
blood pressure, blood sugar and cholesterol are a viable way to delay or
prevent dementia.
Marchione then also quotes Dr. Crane,
“At least for diabetics, the results suggest that good blood-sugar control is
important for cognition.” And, for those without diabetes, he said, “it may be
that with the brain, every additional bit of blood sugar that you have is
associated with higher risk. It changes how we think about thresholds, how we
think about what is normal, what is abnormal.”
Charles Bankhead of The Gupta Guide at
MedPageToday commented, “Nondiabetic
patients who developed dementia had a mean blood glucose level of 115mg/dl in
the preceding 5 years compared with 100mg/dl in similar patients who did not
have dementia. According to Dr. Crane, “the higher levels were associated with
almost a 20% [18% actually] increase in the hazard for dementia.”
This
piece by Paula Span in The
New York Times has another quote from Dr. Crane: “We found a steadily
increasing risk associated with ever-higher blood glucose levels, even in
people who didn’t have diabetes. There’s not threshold, no place where the risk
doesn’t go up any further or down any further.” The association with dementia
kept climbing with higher blood sugar levels and, at the other end of the
spectrum, continued to decrease with lover levels. He said that this held true
even at glucose levels considered normal, she said.
Another recent
article from MedPageToday
ties blood sugar (A1c) levels to cognitive function NOW, not to the far-off
future risk of dementia. The group studied was a population of non-diabetics, aged 50 and up, with
BMIs between 25 and 30. Their mean A1c was 5.8%, with a range from 4.3% to
6.5%. The researchers found that “each of the three cognition parameters
evaluated was significantly associated with A1c levels…”
The article, titled “Blood Sugar Tied
to Cognitive Function,” appeared in The
Gupta Guide, Sanjay Gupta, MD, Editor, and was reviewed by staff of the
Perlman School of Medicine at the University of Pennsylvania. The researchers
“added that ‘lifestyle strategies’ to achieve strict glucose control could
prevent age-related cognitive decline, even in individuals with A1c levels
currently considered normal…”
So, what’s the takeaway? What does it mean to change “how we think
about thresholds, how we think about what is normal, what is abnormal”? Well, well-designed
prospective controlled trials are needed to prove causation, but the association
of progressively higher and lower blood glucose with cognitive function, and
ultimately dementia, even at so-called “normal” and “nondiabetic” blood sugar
levels is undeniably true.
What is considered “normal”? And what
is “prediabetic”? From 1979 to 1997 the threshold for type 2 was two consecutive
visits with a fasting blood glucose of ≥140mg/dl. In 1997, ≥126mg/dl became the
threshold for diabetes. In 2010 the ADA added A1c standards, with an A1c of 6.5%
for diabetes (with a “treatment goal” of 7.0%!), and an A1Cs of 5.7--6.4% regarded
as “pre-diabetic”. Some physicians, notably Richard K. Bernstein, consider 5.8%
to be a full-blown type 2 diabetic. Another, Dr. Ralph DeFronzo, in his Banting
lecture at the 2008 ADA convention, said that “By both pathophysiological
and clinical standpoints, these pre-diabetic individuals with IGT should be
considered to have type 2 diabetes.”
IGT, or Impaired Glucose
Tolerance, is defined as a fasting Oral Glucose Tolerance Test result of
>140 at 2 hours. Statistically, you are 7-10 years away from diabetes and
your heart disease risk is already rising. To test your glucose tolerance,
follow the directions here: http://www.phlaunt.com/diabetes/14046889.php. But if there are no
thresholds for an increased risk of dementia, shouldn’t we all adopt
“‘lifestyle strategies’ to achieve strict glucose control” and thus potentially
“prevent age-related cognitive decline, even in those individuals with A1c
levels currently considered normal…”?
This is very interesting. I've known two older ladies who developed Alzheimer's disease and both of them were sugar freaks. Both were lean, and neither was diabetic. I had heard that aluminum that leached from soda cans might be a factor in Alzheimer's, and both of these ladies drank lots of regular soda. Perhaps it was the sugar in those cans, instead.
ReplyDeleteHi Jan,
DeleteI think so too, and so does my editor. There's lot of serious research going on now on nutrition and disease. I just got a Medscape Alert of a special edition on Cancer and Nutrition. Sugar is the new 'bad boy.' I remember about 3 years ago listening to a lecture in NYC on sugar and brain cancer and how a ketogenic diet helped. The cancer 'feeds' on sugar, but not on ketones. The brain loves ketone bodies for energy. What's scary is what you noted about my piece: Even people with slightly elevated blood sugars are at greater risk of Alzheimer's, and CVD too, as my editor is always pointing out to me (and adding to my copy, with the most recent link).
Obelit 120 mg capsule is an antiobesity preparation that helps obese patients lose weight. Take this medicine with every fat meal. Proper diet and exercise are essential to controlling weight. This Medicine is available in the USA at a cheaper price.
ReplyDelete